Duque to FDA: Ready approval for at-home use COVID-19 antigen test kits | Inquirer News

Duque to FDA: Ready approval for at-home use COVID-19 antigen test kits

/ 10:22 PM January 05, 2022

Duque to FDA: Ready approval for at-home use COVID-19 antigen test kits

FILE PHOTO: Department of Health Secretary Francisco Duque III. INQUIRER

MANILA, Philippines — Health Secretary Francisco Duque III has asked the Food and Drug Administration (FDA) to prepare its approval of registered COVID-19 antigen test kits for home use.

According to Duque, he earlier asked then FDA Director-General Eric Domingo to ensure that the Certificate of Product Registration (CPR) of antigen kits in the country will be revised to expand its approved application.


Domingo recently resigned as FDA chief due to “personal reasons.”


“But I’ve prodded him to make sure that the CPR of the currently available antigen test kits will be revised to include home testing… because now, it’s still done mostly officially in a lab set up,” the DOH chief said during Wednesday’s Go Negosyo forum.

In a separate public briefing, Duque said the DOH is awaiting the recommendation of its technical advisory group on the guidelines for the use of the self-administered COVID-19 antigen test kits.

“Inaantay natin ang rekomendasyon kung ano ang mga dapat malagay sa guidelines para hindi magkamali ang pagbasa ng resulta o pag-interpret ng resulta kung gagamitin ang antigen test kits, self-administered,” he said.

(We are waiting for the recommendation of what are the necessary guidelines in order to prevent error in reading or interpreting the results if antigen tests will be self-administered.)

“Kinakausap ang FDA at sinisiguro natin na magkaroon ng revision dun sa kanilang binigay na CPR kung papano gagamitin ito just in case pahintulutan nila ang self-administered antigen test kits,” he added.

(We are talking to FDA and we are ensuring that there will be a revision of the CPR on how to use the self-administered antigen test kits just in case we approve it.)


Duque also stressed the need to educate the public on how to use the COVID-19 antigen kits.

“The antigen, ‘yung (the) self-administered test, the demand is really great for this, admittedly, but we really have to educate our people how to do it correctly,” he said.

READ: DOH studying use of antigen self-test kits

Meanwhile, an infectious disease expert backed the use of antigen kits at home for faster detection of the virus, especially for those exhibiting symptoms.

“The advantage there is if that if you’re asymptomatic and you get the test and you’re positive, you can isolate yourself, you can do contact tracing early on and prevent the transmission compared to going out and having the RT-PCR [test],” Dr. Rontgene Solante said in the same forum.

Solante is the chief of the Adult Infectious Diseases and Tropical Medicine unit of the San Lazaro Hospital and a member of the Department of Science and Technology’s Vaccine Expert Panel.

On Wednesday, the DOH reported 10,775 additional COVID-19 cases, pushing the country’s active infections total to over 39,000.


Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Expert notes community’s role in preventing Omicron’s spread


For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: antigen, COVID-19, DoH, FDA, Nation, News

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.